SCHEMBL8286455

SCHEMBL8286455

O=C(O)CCc1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 3/20 0.37
AURKA O14965 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
GAA P10253 3/20 0.35
PDE11A Q9HCR9 1/20 0.35
EGLN1 Q9GZT9 3/20 0.34
RHOA P61586 1/20 0.33
GFER P55789 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
CSF1R P07333 1/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
CSNK2A1 P68400 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287259 0.92 GAA (0.34) PLA2G4AGSK3BGAAPDE11AGFER
SCHEMBL8287273 0.92 PDE11A (0.34) PLA2G4AGAAPDE11AGFERHPGD
SCHEMBL8287270 0.91 HSD11B1 (0.40) GSK3AGSK3BGAAPDE11AGFER
SCHEMBL8286560 0.91 MAPT (0.39) GAANPC1HPGD
SCHEMBL8286552 0.90 CCNC (0.37) GAAPDE11AGFERRAB9AHPGD
SCHEMBL8287263 0.90 TSHR (0.40) GSK3AGSK3BGAAPDE11AGFER
SCHEMBL8286557 0.87 NPC1 (0.40) GAAPDE11ANPC1RAB9AFFAR1
SCHEMBL8286554 0.87 ALDH1A1 (0.35) PLA2G4AGSK3BGAAPDE11AEGLN1
SCHEMBL8286175 0.87 GAA (0.36) GSK3BGAAPDE11AGFERHPGD
SCHEMBL8287262 0.86 HSD11B1 (0.46) PDE11AHPGDCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed